THURSDAY, Nov. 14, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and ...
The Company reported a net loss of approximately $8.4 million, or $0.25 per share, for the three months ended September 30, ...
The HC bench said Section 13 (1)(iii) of the Hindu Marriage Act does not make mere existence of a mental disorder of any ...